Comparative Diagnostic Utility of SARS-CoV-2 Rapid Antigen and Molecular Testing in a Community Setting
The Journal of Infectious Diseases2024Vol. 230(2), pp. 363–373
Citations Over TimeTop 18% of 2024 papers
Ashley E. Kim, Julia C. Bennett, Kyle G Luiten, Jessica O’Hanlon, Caitlin R. Wolf, Ariana Magedson, Peter D. Han, Zack Acker, Lani Regelbrugge, Kathryn McCaffrey, Jeremey Stone, David Reinhart, Benjamin J. Capodanno, Stephen S. Morse, Trevor Bedford, Janet A. Englund, Michael Boeckh, Lea M. Starita, Timothy M. Uyeki, Marco Carone, Ana A. Weil, Helen Y. Chu
Abstract
Ag-RDT performance varied by clinical characteristics and temporal testing patterns. Our findings support recommendations for serial testing following an initial Ag-RDT-negative result, especially among recently symptomatic persons or those at high risk for SARS-CoV-2 infection.
Related Papers
- → And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan(2020)27 cited
- → Realizing the Potential of Anti–SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management(2022)21 cited
- → Confirmation of SARS-CoV-2 airborne dissemination indoors using “COVID-19 traps”(2021)4 cited
- → Fachinformationen zu SARS-CoV-2/COVID-19(2020)